Persistently High Neutrophil to Lymphocyte Ratio after Surgery Indicate Poor Prognosis in Non-small Cell Lung Cancer Patients

Annals of Cancer Research and Therapy

Volumn 19, Issue 2, 2011, Pages 54-56

  Tomita, Masaki ^a   Shimizu, Tetsuya ^a   Ayabe, Takanori ^a   Onitsuka, Toshio ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

neutrophil to lymphocyte ratio; non small cell lung cancer; postoperative; preoperative high; prognosis

Indexed keywords

EID: 84917739622     PISSN: 13446835     EISSN: None     Source Type: Journal    
DOI: 10.4993/acrt.19.54     Document Type: Article

References (15)

1. Paesmans M, Soulier JP, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Cutsem O, Sergysels R, Mommen P. (1995) Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 13: 1221-1230.
2. Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K, Fukushima M. (2009) Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 45: 1950-1958.
3. Tibaldi C, Vasile E, Bernardini I, Orlandini C, Andreuccetti M, Falcone A. (2008) Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model. J Cancer Res Clin Oncol 134: 1143-1149.
4. Ferrigno D, Buccheri G. (2003) Hematologic counts and clinical correlates in 1201 newly diagnosed lung cancer patients. Monaldi Arch Chest Dis 59: 193-198.
5. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 137: 425-428.
6. Tomita M, Shimizu T, Ayabe T, Yonei A, Onitsuka T. (2011) Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Non-small Cell Lung Cancer. Anticancer Res 31: 2995-2998.
7. Yoneyama Y, Ito M, Sugitou M, Kobayashi A, Nishizawa Y, Saito N. (2011) Postoperative lymphocyte percentage influences the long-term disease-free survival following a resection for colorectal carcinoma. Jpn J Clin Oncol. 41: 343-347.
8. Thavaramara T, Phaloprakarn C, Tangjitgamol S, Manusirivithaya S. (2011) Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai. 94: 871-877.
9. Icard P, Regnard JF, Essomba A, Panebianco V, Magdeleinat P, Levasseur P. (1994) Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. Ann Thorac Surg 58: 811-814.
10. Rubins JB, Dunitz J, Rubins HB, Maddaus MA, Niewoehner DE. (1998) Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 116: 412-416.
11. Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T. (2004) Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. Ann Thorac Cardiovasc Surg 10: 76-80.
12. Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M. (2004) Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Cancer 101: 803-809.
13. Tomita M, Matsuzaki Y, Shimizu T, Hara M, Ayabe T, Onitsuka T. (2005) Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels. Thorac Cardiovasc Surg 53: 300-304.
14. O'Callaghan DS, O'Donnell D, O'Connell F, O'Byrne KJ. (2010) The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol 5: 2024-2036.
15. Tauler J, Mulshine JL. (2009) Lung cancer and inflammation: interaction of chemokines and hnRNPs. Curr Opin Pharmacol. 9: 384-388.